Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
943.71
705.14
787.65
587.37
810.46
729.26
1,122.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
943.71
705.14
787.65
587.37
810.46
729.26
1,122.60
Raw Material Cost
28.36
33.20
31.63
36.22
30.40
29.11
20.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
90.54
90.45
81.46
8.12
9.35
9.51
48.77
Selling and Distribution Expenses
383.86
245.48
210.12
128.19
166.79
337.16
271.17
Other Expenses
82.26
81.11
81.82
82.50
63.41
52.56
41.64
Total Expenditure (Excl Depreciation)
1,325.39
1,180.22
1,141.38
997.56
840.64
901.35
756.72
Operating Profit (PBDIT) excl Other Income
-381.70000000000005
-475.09999999999997
-353.7
-410.20000000000005
-30.2
-172.10000000000002
365.90000000000003
Other Income
82.41
108.35
89.74
167.66
8.91
30.50
51.52
Operating Profit (PBDIT)
-276.58
-344.74
-241.50
-220.42
-1.71
-124.42
433.40
Interest
90.54
90.45
81.46
8.12
9.35
9.51
48.77
Exceptional Items
10.22
-2.89
11.49
-7.33
1.48
16.54
-21.86
Gross Profit (PBDT)
915.36
671.93
756.02
551.15
780.05
700.16
1,102.22
Depreciation
22.69
21.99
22.50
22.11
19.56
17.16
15.99
Profit Before Tax
-379.60
-460.07
-333.96
-257.99
-29.15
-134.55
346.77
Tax
1.79
-6.17
32.32
11.74
-0.55
345.19
43.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-381.39
-453.90
-366.29
-269.72
-28.60
-444.26
296.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-381.39
-453.90
-366.29
-269.72
-28.60
-444.26
296.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
-35.48
9.12
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-381.39
-453.90
-366.29
-269.72
-28.60
-479.74
305.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
489.09
588.35
386.69
572.89
771.74
743.28
1,471.09
Earnings per share (EPS)
-2.38
-3.04
-2.56
-1.9
-0.2
-3.18
2.08
Diluted Earnings per share
-2.38
-3.04
-2.56
-1.9
-0.2
-3.18
2.08
Operating Profit Margin (Excl OI)
-40.45%
-67.37%
-44.91%
-69.84%
-3.72%
-23.6%
32.59%
Gross Profit Margin
-37.82%
-62.13%
-39.54%
-40.16%
-1.18%
-16.1%
32.31%
PAT Margin
-40.41%
-64.37%
-46.5%
-45.92%
-3.53%
-60.92%
26.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 33.84% vs -10.47% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 15.97% vs -23.91% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 20.77% vs -36.81% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 11.04% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Ionis Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
943.71
2,320.13
-1,376.42
-59.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
943.71
2,320.13
-1,376.42
-59.33%
Raw Material Cost
28.36
83.70
-55.34
-66.12%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
90.54
0.00
90.54
Selling and Distribution Expenses
383.86
518.73
-134.87
-26.00%
Other Expenses
82.26
82.50
-0.24
-0.29%
Total Expenditure (Excl Depreciation)
1,325.39
1,427.43
-102.04
-7.15%
Operating Profit (PBDIT) excl Other Income
-381.68
892.70
-1,274.38
-142.76%
Other Income
82.41
69.02
13.39
19.40%
Operating Profit (PBDIT)
-276.58
990.77
-1,267.35
-127.92%
Interest
90.54
0.00
90.54
Exceptional Items
10.22
-20.51
30.73
149.83%
Gross Profit (PBDT)
915.36
2,236.43
-1,321.07
-59.07%
Depreciation
22.69
29.05
-6.36
-21.89%
Profit Before Tax
-379.60
941.21
-1,320.81
-140.33%
Tax
1.79
158.64
-156.85
-98.87%
Provisions and contingencies
0
0
0.00
Profit After Tax
-381.39
782.57
-1,163.96
-148.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-381.39
782.57
-1,163.96
-148.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-381.39
782.57
-1,163.96
-148.74%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
489.09
2,161.32
-1,672.23
-77.37%
Earnings per share (EPS)
-2.38
2.78
-5.16
-185.61%
Diluted Earnings per share
-2.38
2.78
-5.16
-185.61%
Operating Profit Margin (Excl OI)
-40.45%
38.48%
0.00
-78.93%
Gross Profit Margin
-37.82%
41.82%
0.00
-79.64%
PAT Margin
-40.41%
33.73%
0.00
-74.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 94.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 33.84% vs -10.47% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -38.14 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.97% vs -23.91% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -35.90 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.77% vs -36.81% in Dec 2024
Annual - Interest
Interest 9.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 11.04% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -40.45%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
